Indeed, autophagy regulation has been proposed as a therapy to reduce the risk of obesity-associated cardiovascular diseases (Castaneda et al. 2019). Thus, ATG2A may participate in a positive feedback loop in which lower expression of ATG2A is both a cause and a consequence of obesity. The gene discussed is ATG2A; the disease is obesity due to melanocortin 4 receptor deficiency.